Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)

Name: Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)
Published: 2016
License: Public Domain

GlaxoSmithKline · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

neoplasms pembrolizumab

neoplasms, icos receptor agonist antibody, pembrolizumab, keynote-478, gsk3359609, cohort expansion, dose escalation, dostarlimab, cobolimab, bintrafusp alfa, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)

Related documents